
Share
Revenue climbed 9% and margins widened as the nonprofit giant leaned into efficiency and value-based care. But a drop in investment returns shows how exposed even healthcare's biggest balance sheets remain to market swings.
Kaiser Permanente's third-quarter numbers tell two stories at once. Operating performance improved meaningfully. Bottom-line profit did not.
The country's largest nonprofit health system, together with its subsidiaries, posted $34.7 billion in operating revenue for the three months ended Sept. 30, up 9% year over year. Operating expenses came in at $34.2 billion, leaving operating income of $495 million, good for a 1.4% operating margin. That compares favorably to the prior year's $218 million and 0.7% margin, a more than doubling of operating income on a percentage basis.
That margin expansion matters in a sector where thin operating margins are the norm rather than the exception. Kaiser itself has flagged that margins typically compress as the year progresses, tied to health plan enrollment cycles and seasonal expense timing. The fact that margin still improved year over year, even against that seasonal headwind, suggests the underlying cost and revenue trends are moving in the right direction.
Net income tells a less flattering story. Kaiser collected $1.8 billion in investment and other income during the quarter, down sharply from nearly $2.4 billion a year earlier. That gap pulled net income to roughly $2.3 billion, below last year's $2.6 billion, even as operating income more than doubled. It's a reminder that for an organization of Kaiser's scale, investment portfolio performance can swing bottom-line results as much as, or more than, core operations.
CEO Greg Adams framed the quarter's results around affordability and value-based care, telling stakeholders that Kaiser's rates run "12% to 18% lower than our competitors', on average, when comparing similar products." The organization is explicitly tying its investment priorities to measurable outcomes rather than volume, a positioning that aligns with broader industry pressure to control costs amid persistent affordability concerns among employers and patients alike.
That strategy is playing out through Risant Health, Kaiser's subsidiary value-based care platform, which continues to expand via acquisition. The system recently announced plans to add Oklahoma's Integris Health, a $3.3 billion system comprising 10 acute and 10 specialty hospitals, to the Risant portfolio. The deal is expected to close early next year, though Kaiser's announcement offered no financial terms. A more detailed regulatory filing, typically submitted a few weeks after the topline release, may shed further light on how the Integris transaction is structured and financed.
Capital spending held roughly steady at $1.2 billion for the quarter, down modestly from $1.3 billion a year ago. That spending spans more than five dozen active projects, including seven major hospital construction efforts. CFO Kathy Lancaster noted progress on infrastructure tied to hospital seismic compliance requirements, along with continued investment in facilities and technology supporting inpatient, ambulatory and telehealth care. The seismic spending in particular reflects a cost burden unique to California-heavy systems like Kaiser, where regulatory deadlines for hospital retrofits have forced sustained capital outlays regardless of near-term earnings pressure.

Membership across Kaiser and Risant stood at nearly 13.4 million at quarter's end, essentially flat against the second quarter. Flat membership alongside 9% revenue growth points to rate increases and service mix shifts doing more of the heavy lifting than enrollment growth, worth watching as the system continues to layer new systems into Risant.
Kaiser also disclosed close to $1.0 billion in charitable grants, loans and investments aimed at strengthening community healthcare infrastructure, including about $315 million in financial assistance and charity care. For a nonprofit system, that community investment figure carries as much reputational weight as any margin number, particularly as scrutiny of nonprofit hospital tax exemptions continues to build in Washington and in state legislatures.
Zooming out, the quarter fits a longer arc. Kaiser reported $127.7 billion in operating revenue for full-year 2025, a 44% jump since 2020, driven substantially by Risant's affiliate acquisitions. Last year's full-year operating income came in at $1.4 billion, a 1.1% margin, alongside $9.3 billion in net income and $4.8 billion in capital spending. Against that backdrop, this quarter's $495 million operating income and 1.4% margin look consistent with, if not slightly ahead of, the trajectory management has been building toward.
Kaiser's operating business is getting stronger. Revenue growth of 9%, operating income more than doubling, and margin improvement despite seasonal headwinds all point to effective cost discipline paired with continued top-line momentum. That's the core thesis for a nonprofit system betting its growth strategy on value-based care and scale through Risant.
The net income miss is the caveat. A $1.8 billion investment income haul, down from $2.4 billion, is a market-driven outcome largely outside management's control, but it's the kind of volatility investors and bondholders in the nonprofit hospital space need to underwrite. Kaiser doesn't have public equity to answer to, but its credit profile and borrowing costs are directly tied to these swings.
Watch the Integris Health integration closely once the more detailed regulatory filing lands. A $3.3 billion acquisition folded into Risant without disclosed financial terms raises reasonable questions about valuation and expected returns. If Kaiser can replicate its operating margin gains across an expanding, acquisition-heavy platform, the growth story holds. If investment income volatility recurs alongside rising capital commitments for seismic compliance and hospital construction, the net income line may keep lagging the operating story for several quarters to come.
Tags
Original Sources
Kaiser Permanente grows revenue 9%, doubles operating margin in Q3 2026
↗ https://www.fiercehealthcare.com/providers/kaiser-permanente-grows-revenue-9-doubles-operating-margin-q3-2026
About the author
Marcus began tracking AI's market implications in 2016, noticing AI-related patent filings accelerating ahead of earnings upgrades before most of the sell-side had caught on. A former fixed-income quantitative analyst, he spent two decades building models that priced risk across emerging markets before pivoting to cover the economic impact of AI full-time. His writing translates opaque technical developments into clear risk/reward terms — and he's rarely diplomatic about the gap between AI valuations and underlying fundamentals. He believes most market participants still underestimate AI's long-run deflationary effect on knowledge work.
More from The Analyst →This Week's Edition
11 November 2026
14 articles
Related Articles
Related Articles
More Stories
© 2026 Cedar & Bloom. All rights reserved.